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In This IssueTargeting Protein-Protein Interactions: Bring
It On!
PAGE 689
Protein-protein interactions (PPIs) mediate numerous biological processes.
This makes finding small molecules that target PPIs of high interest. But finding
such small molecules continues to be a challenge. Laraia et al. review the spe-
cific challenges of developing PPI inhibitors and highlight four innovations they
consider critical to overcome these challenges.Inhibition of AMPK and Insulin Release
PAGE 705
AMP-activated protein kinase (AMPK) is a central regulator of energy meta-
bolism. Therapeutic AMPK inhibition is regarded as a strategy to combat
diabetes, cancers, and neurodegeneration. Scott et al. have identified MT47-100 as an AMPK inhibitor acting through an
allosteric drug-binding site. These findings will aid development of AMPK-targeting therapeutics.hRAD51 AND HIV-1: Bosom Bodies or Arch Enemies
PAGE 712
HIV-1 replication depends on the integration of the viral genome into the infected cell DNA. This step can bemodulated by the
hRAD51DNA repair protein. Pharmacological strategies, employed by Thierry et al., establish a direct correlation between the
stimulation of hRAD51 and the inhibition of HIV-1 integration highlighting the multiple and opposite regulatory functions of
the recombinase on this important replication step.Pseudoglycosyltransferase VldE
PAGE 724
Abuelizz and Mahmud used OtsA, VldE, and chimeric proteins to study pseudoglycosyltransferase catalysis. They found that
the N-terminal domain of VldE is responsible for its distinct substrate specificity and catalytic activity and that the chimeric
proteins can produce hybrid pseudo-aminodisaccharides.Cladosporin’s Species Selectivity Explained
PAGE 734
Cladosporin is a potent antimalarial targeting the lysyl-tRNA Synthetase
(LysRS), with strict species selectivity. Fang et al. present structural and
biochemical analyses of the LysRS-cladosporin complexes, revealing a surpris-
ing molecular basis for the species and family selectivity through binding the
universal pocket of ATP.From DNA Fragments to Mechanism of
Macrodiolide Formation
PAGE 745
Zhou et al. describe the in vitro cloning from genomic DNA fragments of
the intact biosynthetic gene cluster for conglobatin. This provides proof ofconcept for more convenient recovery of large gene clusters for both known and silent biosynthetic pathways, enabling their
detailed analysis.Hijacking Cereblon to Target BRD4
PAGE 755
Lu et al. designed a potent BRD4 degrader using the PROTAC technology by recruiting BRD4 to the E3 ligase cereblon. This
study demonstrates the potential of hijacking cereblon or other E3 ligases through the PROTAC platform for effectively tar-
geting pathological proteins as a therapeutic approach.Chemistry & Biology 22, June 18, 2015 ª2015 Elsevier Ltd All rights reserved v
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PAGE 764
Vardy et al. compare the activation of opioid receptors from human and frogs. Deltorphin, an opioid peptide secreted by frogs,
was shown to be highly potent in the human DOR but inactive in the frog receptor. Bioinformatics, structural analysis, and
extensive mutagenesis revealed that a single amino acid is responsible for the species selectivity exhibited by deltorphin.A Playful EGFR Juxtamembrane Region
PAGE 776
Doerner et al. report that the EGFR juxtamembrane region assembles into three
different anti-parallel coiled coils whose structure both depends on growth fac-
tor identity and correlates with downstream signaling. Alternative coiled coils
communicate chemical information across the plasma membrane.
Saying ‘‘Yes’’ to Targeting NOS
PAGE 785
Holden et al. report on novel bacterial nitric oxide synthase (bNOS) inhibitors
that work synergistically with agents that induce oxidative stress to dramatically
inhibit the growth of methicillin resistant Staphylococcus aureus (MRSA).
Cobalt(III) Protoporphyrin and miRNA Processing
PAGE 793
miRNA processing defects have been reported in many human diseases including 22q11.2 deletion syndrome. Barr et al.
show that Co(III) protoporphyrin activates miRNA processing by binding and activating the RNA-binding protein DGCR8
and compensates processing deficiency in Dgcr8+/ mouse neurons.vi Chemistry & Biology 22, June 18, 2015 ª2015 Elsevier Ltd All rights reserved
